ELISA Screening Equipment ( Forensic Immunoassay )

The State of Oregon, specifically the Oregon State Police Forensics Laboratory and jurisdictions of Marion County and the City of Salem, is conducting a Request for Proposals (RFP No. S-DASOBO-00001933) for ELISA Screening Equipment designed for forensic immunoassays. The procurement seeks a minimum of two liquid-handling systems capable of performing comprehensive drug screening through antibody-based testing in blood and urine matrices. Key technical requirements include automated microplate absorbance reading, strip washing capabilities, specific software interfaces, and the ability to perform mandatory and preferred drug assays. Vendors must demonstrate technical support capacity, including on-site training for agency staff on instrument preparation, analysis software usage, and preventative maintenance practices. The evaluation criteria are structured across five groups, with a total of 630 available points, and pricing will account for 200 points of the total score. The proposal submission deadline is March 31, 2022, at 11:30 AM PST, with the procurement team anticipating a single award based on the comprehensive evaluation of technical capabilities and pricing.

The RFP encourages participation from COBID-certified firms, specifically highlighting opportunities for minority-owned, woman-owned, service-disabled veteran-owned, and emerging small businesses. Proposers are required to complete a Certified Disadvantaged Business Outreach Plan, detailing their strategy for soliciting and engaging certified businesses as potential subcontractors. While specific budget ranges are not explicitly stated in the documentation, the procurement involves acquiring advanced forensic screening equipment with comprehensive support services. Vendors must provide proof of insurance, tax documentation, and other compliance information prior to contract execution. The sample contract indicates a potential initial contract term with options for extension, and includes standard provisions for software licensing, maintenance, confidentiality, and indemnification. The procurement emphasizes not just equipment acquisition but also ongoing technical support, research capabilities for cross-reactivity of new drugs, and comprehensive training services.